Biography
Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.
Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).
Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.
Since 2014, Dr. Conte has been named to Castle Connolly’s list of Top Doctors.
Videos
Education
| Institution | Degree | Dept or School | End Date |
|---|---|---|---|
| University of California | Diversity, Equity, and Inclusion Champion Training | 2018 | |
| Brigham and Women's Hospital | Clinical Fellow | Vascular Surgery | 1994 |
| Harvard Medical School | Clinical Fellow | Vascular Surgery | 1994 |
| New York Hospital | Chief Resident | General Surgery | 1993 |
| New York Hospital | Senior Resident | General Surgery | 1992 |
| Harvard Medical School | Research Fellow | Vascular Surgery | 1991 |
| New York Hospital | Senior Resident | General Surgery | 1989 |
| New York Hospital | Junior Resident | General Surgery | 1988 |
| Albert Einstein College of Medicine | M.D. | Medicine | 1986 |
| Boston University | B.S. | Biomedical Engineering | 1982 |
Board Certifications
- American Board of Surgery, General Surgery, 1994
- American Board of Surgery, Vascular Surgery, 1996
Awards & Honors
| Award | Conferred By | Date |
|---|---|---|
| Peripheral Vascular Disease Distinguished Achievement Award | American Heart Association | 2019 |
| Bay Area Top Doctors | San Francisco Magazine | 2016 |
| Best Doctors in America | Best Doctors, Inc. | 2015 |
| T1 Catalyst Award Finalist | UCSF Clinical and Translational Sciences Institute (CTSI) | 2012 |
| Best Doctors in America | Best Doctors, Inc. | 2009 |
| Best Doctors in Boston | Best Doctors, Inc. | 2007 |
| Distinguished Achievement Award | New York Weill Cornell Medical Center Alumni Council | 2006 |
| Mentored Clinical Scientist Development Award | NHLBI/Lifeline | 1999 |
| Fellowship Award | American Surgical Association Foundation | 1997/1999 |
| Research Award | Lifeline Foundation | 1988 |
| Alpha Omega Alpha | Medical Honor Society | 1986 |
| Tau Beta Pi | National Engineering Honor Society | 1982 |
Clinical Expertise
Abdominal Aortic Aneurysm
Carotid Artery Disease
Complex Limb Revascularization
Critical Limb Ischemia
Diabetic Vascular Disease
Dialysis Access
Endovascular Aneurysm Repair
Mesenteric Artery Disease
Peripheral Artery Disease
Thoracic Aortic Aneurysm
Thoracic Outlet Syndrome
Program Affiliations
Cardiovascular Research Institute (CVRI)
UCSF Heart and Vascular Center
Grants and Funding
- UCSF Diabetic Foot Clinical Research Unit | NIH | 2018-09-15 - 2027-12-31 | Role: Principal Investigator
- Tissue Oxygen Monitoring in Peripheral Vascular Disease | NIH | 2016-04-01 - 2021-07-31 | Role: Co-Principal Investigator
- Specialized lipid mediators and mechanisms of resolution in vascular injury | NIH | 2013-08-21 - 2018-05-31 | Role: Principal Investigator
- IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014 | NIH | 2013-11-15 - 2014-11-14 | Role: Principal Investigator
- Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling | NIH | 2007-08-01 - 2013-06-30 | Role: Principal Investigator
- General Clinical Research Center | NIH | 1984-12-01 - 2010-03-31 | Role: Co-Investigator
- GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT | NIH | 1999-09-07 - 2004-08-31 | Role: Principal Investigator
Research Narrative
Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.
Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.
Research Pathways
Publications
- Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI Trial.| |
PubMed
- UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.| |PubMed
- Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia.| |PubMed
- Discoloration, radiopacity, and push-out bond strength of bismuth-based radiopacifiers in endodontic sealers.| |PubMed
- Reply to the Letter to the Editor: "Diabetes Increases Residual Stress and Microcrack Length in Dentin: An XRD-SEM Study with AI-assisted Quantification".| |PubMed
- Validation of the Society for Vascular Surgery Appropriate Use Criteria for management of intermittent claudication.| |PubMed
- Early Improvement in Wound, Ischaemia, and foot Infection (WIfI) Ischaemia Grade Lowers Risk of Major Amputation following Revascularisation for Chronic Limb Threatening Ischaemia.| |PubMed
- Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis.| |PubMed
- The Diabetic Foot Consortium Biomarker Platform Study: A New Approach to Advance Diabetic Foot Ulcer Healing.| |PubMed
- Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization.| |PubMed